149 related articles for article (PubMed ID: 8698067)
21. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
22. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine.
Hölzer T
Neurosurgery; 1998 May; 42(5):1200-1. PubMed ID: 9588575
[No Abstract] [Full Text] [Related]
23. Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.
Schaider H; Haberkorn U; Berger MR; Oberdorfer F; Morr I; van Kaick G
Eur J Nucl Med; 1996 Jan; 23(1):55-60. PubMed ID: 8586103
[TBL] [Abstract][Full Text] [Related]
24. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.
Dethy S; Goldman S; Blecic S; Luxen A; Levivier M; Hildebrand J
J Nucl Med; 1994 Jul; 35(7):1162-6. PubMed ID: 8014676
[TBL] [Abstract][Full Text] [Related]
25. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
[TBL] [Abstract][Full Text] [Related]
26. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
[TBL] [Abstract][Full Text] [Related]
27. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
28. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
[TBL] [Abstract][Full Text] [Related]
29. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Vandesteene A; Salmon I; Brotchi J; Levivier M
J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051
[TBL] [Abstract][Full Text] [Related]
31. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
Fulham MJ; Brunetti A; Aloj L; Raman R; Dwyer AJ; Di Chiro G
J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
[TBL] [Abstract][Full Text] [Related]
32. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Torizuka T; Clavo AC; Wahl RL
J Nucl Med; 1997 Mar; 38(3):382-6. PubMed ID: 9074524
[TBL] [Abstract][Full Text] [Related]
33. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
[TBL] [Abstract][Full Text] [Related]
34. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
35. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.
Ribom D; Schoenmaekers M; Engler H; Smits A
J Neurooncol; 2005 Feb; 71(3):325-32. PubMed ID: 15735925
[TBL] [Abstract][Full Text] [Related]
39. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
40. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
